-
Fury, Joshua kick off 'battle of Britain' in good spirits
-
Kanye West's Russian concerts have been cancelled, organisers say
-
Ronaldo leaves Portugal training camp after coach says he is dropped
-
First Hollywood, now Fat Bear Week: nepobaby wins Alaska contest
-
Florence Pugh stars in 'East of Eden' adaption on Netflix
-
Barcelona lay down marker in Women's Champions League, Arsenal slip up
-
Watchdog finds no criminal misconduct over US Fed renovations despite Trump probe
-
US pushes against overproduction with eye on China at G20 meeting
-
In Manchester, City fans 'devastated' while rival fans call for relegation
-
Swiss FA withdraws support for FIFA chief Infantino
-
UK-France Channel migrant exchange deal scrapped: London
-
Man City's meteoric rise clouded by financial scandal
-
Portugal boss denies 'incident' with Ronaldo
-
Polish activists open first abortion pill locker in Warsaw
-
Israel PM says one of the pilots of rerouted flight tried to crash plane
-
NHL Avalanche ink Bednar to four-year coaching deal
-
Manchester City: Main points of damning judgement and possible sanctions
-
Polish activists opens first abortion pill locker in Warsaw
-
Italy looking for 'identity' under Mancini says Scalvini
-
Turkey says news site closed for 'LGBTQ propaganda'
-
The voices of Spain's housing camp protesters
-
Oil companies close in on Venezuela despite hurdles
-
Romanian parliament rejects pro-EU PM candidate
-
Turkey freezes ex-minister's assets as fund scandal grows
-
Court halts Tennessee's first execution of woman in 200 years
-
Guardiola backs Man City after bombshell guilty verdicts
-
Israelis march between once-closed West Bank settlements
-
G20 trade ministers open talks under strain of Trump tariffs
-
'Welcome back,' says Macron, as UK PM opens door to EU return
-
France in talks with UK to end 2025 migrant accord: ministry
-
Israel PM says pilot of rerouted flight tried to crash plane
-
Europe's surging inflation spreads gloom in stock markets
-
Demuro hopes to deliver Japan a 'magical' Arc victory
-
Truth commission demands compensation for Sweden's Sami people
-
'Devastated' AI scandal author Orelien returns to Quebec
-
Japan win marathon penalty shootout to set up South Korea gold-medal clash
-
US reports firm Q2 economic growth, inflation steady
-
Djokovic grinds out opening-round win at China Open
-
Energy costs spark inflation surge across Europe
-
Northern Ireland police probe blockade of disputed parade
-
Parma appoint Italy World Cup winner Gilardino
-
UK PM Burnham reopens divisive debate on rejoining EU
-
West Indies pile up record 405-7 in second ODI against India
-
Man City future in doubt after guilty verdict
-
Romanian parliament rejects pro-EU PM candidate amid political deadlock
-
'Do something,' begs Iranian woman after death sentence over protests
-
Passenger on rerouted flydubai flight says pilot tried to crash plane
-
China extends 52-year unbeaten record as Games organisers say sorry
-
Russia targets Kyiv power supply as freezing winter approaches
-
In Manchester, people say City scandal is 'shame for football'
First no-prescription birth control pill approved in US
US health authorities on Thursday approved the first over-the-counter birth control pill in the country, dramatically widening access to contraception for women in the United States where abortion rights are increasingly under assault.
The medication, Opill, will become available in pharmacies and supermarkets as well as online early next year, the manufacturer Perrigo said in a statement.
More than 100 countries already allow contraceptive pills to be sold over the counter. But in the United States approval comes after the Supreme Court last year scrapped federal abortion protections and the procedure is now banned in several states.
"Today's approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States," said Patrizia Cavazzoni, director of the Food and Drug Administration's Center for Drug Evaluation and Research in a statement.
"When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy."
The agency warned, however, that the pill should not be taken by women who have or have ever had breast cancer.
- 'Victory for equity' -
Almost half of the 6.1 million pregnancies in the United States each year are unintended, according to the FDA.
Allowing women to access the progestin-only daily contraceptive pill without needing to see a doctor first "may help reduce the number of unintended pregnancies and their potential negative impacts," the FDA statement said.
The pill, produced by the pharmaceutical company HRA Pharma, which was recently acquired by Perrigo, had already been authorized for prescription in the United States for a number of years.
"This moment is a victory for equity, human rights, public health, and evidence-based research—and especially in light of the ongoing attacks on reproductive health and rights, it is a reason to celebrate," said the Free the Pill coalition, a leading advocacy group.
Experts say the decision could be especially significant for teenage girls who may find it harder to get to the doctor, particularly if they want to do it on their own.
"An over-the-counter birth control pill has the potential to transform the way people access contraception, especially those who face the most barriers in our health care system, including LGBTQIA+ folks, people of color, and those working to make ends meet," said Lin-Fan Wang, a family physician serving the LGBTQ community and a Free the Pill member.
In May, an expert advisory committee convened by the FDA unanimously voted in favor of authorizing the sale of Perrigo without a prescription, judging that the benefits outweighed the risks.
The contraceptive pill, taken daily at the same time, prevents a pregnancy during sexual intercourse.
T.Bondarenko--BTB